ReviewAmerican heart journal plus : cardiology research and practice2026
Precision-guided heart failure interventions: The expanding role of advanced cardiac imaging and artificial intelligence.
Review in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure remains a major driver of hospitalization, morbidity, impaired quality of life, and healthcare expenditure. As disease phenotypes become more diverse and therapeutic options expand beyond pharmacological treatment alone, contemporary heart failure care increasingly includes transcatheter valve therapies, cardiac resynchronization and pacing strategies, complex coronary interventions, invasive hemodynamic assessment, implantable pressure sensors, and advanced heart failure therapies. This evolution has made precision in three domains increasingly important: anatomy, myocardial substrate, and physiology. Advanced cardiac imaging is central to this transition. Echocardiography remains the front-line modality for functional assessment, hemodynamics, and procedural guidance. Cardiac magnetic resonance refines etiologic diagnosis through ventricular quantification, scar assessment, and tissue characterization. Cardiac computed tomography provides high-resolution anatomic planning for structural and coronary interventions. Nuclear imaging offers selected value in perfusion, viability, inflammation, and sympathetic innervation. In parallel, remote hemodynamic monitoring supports earlier recognition of congestion, while artificial intelligence may improve segmentation, standardization, workflow efficiency, and risk prediction. This narrative review synthesizes the role of advanced cardiac imaging and artificial intelligence across the pre-procedural, intra-procedural, and post-procedural pathway in heart failure interventions. We propose a pragmatic precision-care framework that integrates multimodality imaging, invasive physiology, remote monitoring, and patient-centered outcomes. We also highlight current limitations, including heterogeneous evidence, variable access, procedural non-response, data fragmentation, and the need for external validation before broad implementation of artificial intelligence-supported decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.